Biocartis

PRESS RELEASE: REGULATED INFORMATION12 May 2023, 17:40 CEST…

PRESS RELEASE: REGULATED INFORMATION20 April 2023, 07:00 CEST…

PRESS RELEASE: REGULATED INFORMATION 11 April 2023, 07:01 CEST…

PRESS RELEASE: 4 April 2023, 07:00 CEST Biocartis and APIS Assay…

PRESS RELEASE - REGULATED INFORMATION 29 March 2023, 07:00 CEST…

<!-- Name:DistributionId Value:1000784458 --> <!-- Name:EnableQuoteCarouselOnPnr Value:False --> <!-- Name:IcbCode Value:4533 -->…

<!-- Name:DistributionId Value:1000782956 --> <!-- Name:EnableQuoteCarouselOnPnr Value:False --> <!-- Name:IcbCode Value:4533 -->…

PRESS RELEASE:  REGULATED INFORMATION17 January 2023, 17:40 CET BIOCARTIS MEETS 2022 KEY OBJECTIVES Mechelen, Belgium, 17 January 2023 - Biocartis Group NV (the ‘Company’ or ‘Biocartis’), an innovative molecular diagnostics company…

PRESS RELEASE: REGULATED INFORMATION16 January 2023, 17:40 CET Completion of Comprehensive Recapitalization Transactions Mechelen, Belgium, 16 January 2023 –Biocartis Group NV (the "Company" or "Biocartis"), an innovative molecular…

PRESS RELEASE: REGULATED INFORMATION16 December 2022, 17:40 CET Completion of Mandatory Conversion Capitalized terms not otherwise defined in this notice shall have the meaning given to them in the Terms and Conditions of the Bonds.…